Cargando…
P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429920/ http://dx.doi.org/10.1097/01.HS9.0000973580.07128.32 |
| _version_ | 1785090831513812992 |
|---|---|
| author | Krishnamurthy, Pramila Gianatsi, Myrsini Wintrich, Sophie Thomas, Abin Quek, Lynn Kulasekararaj, Austin Mehta, Priyanka Munisamy, Sreetharan Russell, Nigel Dennis, Mike Payne, Elspeth Thomas, Ian |
| author_facet | Krishnamurthy, Pramila Gianatsi, Myrsini Wintrich, Sophie Thomas, Abin Quek, Lynn Kulasekararaj, Austin Mehta, Priyanka Munisamy, Sreetharan Russell, Nigel Dennis, Mike Payne, Elspeth Thomas, Ian |
| author_sort | Krishnamurthy, Pramila |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429920 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104299202023-08-17 P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS Krishnamurthy, Pramila Gianatsi, Myrsini Wintrich, Sophie Thomas, Abin Quek, Lynn Kulasekararaj, Austin Mehta, Priyanka Munisamy, Sreetharan Russell, Nigel Dennis, Mike Payne, Elspeth Thomas, Ian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429920/ http://dx.doi.org/10.1097/01.HS9.0000973580.07128.32 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Krishnamurthy, Pramila Gianatsi, Myrsini Wintrich, Sophie Thomas, Abin Quek, Lynn Kulasekararaj, Austin Mehta, Priyanka Munisamy, Sreetharan Russell, Nigel Dennis, Mike Payne, Elspeth Thomas, Ian P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_full | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_fullStr | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_full_unstemmed | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_short | P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS |
| title_sort | p1677: defining key quality of life metrics in acute myeloid leukaemia and high risk myelodysplastic syndrome patients enrolled in large-scale uk ncri aml trials |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429920/ http://dx.doi.org/10.1097/01.HS9.0000973580.07128.32 |
| work_keys_str_mv | AT krishnamurthypramila p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT gianatsimyrsini p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT wintrichsophie p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT thomasabin p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT queklynn p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT kulasekararajaustin p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT mehtapriyanka p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT munisamysreetharan p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT russellnigel p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT dennismike p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT payneelspeth p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials AT thomasian p1677definingkeyqualityoflifemetricsinacutemyeloidleukaemiaandhighriskmyelodysplasticsyndromepatientsenrolledinlargescaleukncriamltrials |